Kratos: Q2 Beat Tempers Some Concerns, But Margin Inflection Still Unproven

What happened

Kratos delivered a strong Q2 earnings beat and raised forward guidance, with backlog now at $2.08B, but the investment case still hinges on converting that backlog into cash and margin improvement. The recent stock pullback has brought valuation down from extreme levels, yet at current prices the market continues to discount a long-term drone and autonomy story rather than near-term free cash flow. The company's resilient near-term revenues and capacity expansion are real, but negative free cash flow and an unmanned segment generating only marginal operating income keep the risk elevated. The next few quarters must show DSO and inventory stabilizing, funded backlog growing, and Valkyrie production awards expanding beyond the initial 24-unit lot. Until those signals appear, the stock remains a high-beta call on execution rather than a value-based buy.

Implication

The Q2 beat and raised guidance reduce some near-term uncertainty, but the core issue remains: KTOS trades at a premium to current earnings power because the market is paying for a terminal story. Working capital metrics (DSO, unbilled receivables, inventory) have been deteriorating and must improve before free cash flow can turn positive. The company's balance sheet is strong with $1.46B cash and no debt, which limits solvency risk, but per-share value creation is still unproven after heavy dilution. Investors should monitor the next two quarterly reports for funded backlog growth, operating cash flow trends, and any Valkyrie follow-on awards. Accumulate only on signs that margin and cash conversion are actually inflecting; otherwise, the downside risk to $34 remains.

Thesis delta

Prior WAIT thesis centered on negative FCF and high valuation despite a promising drone narrative. The Q2 earnings beat and raised guidance modestly improve the near-term outlook, but the core concern of margin improvement and cash conversion remains unresolved. The thesis shifts from a pure WAIT to a cautious buy only if upcoming quarters confirm that working capital stabilizes and Valkyrie expands beyond the 24-unit lot; otherwise, the WAIT stands.